Left atrial appendage occlusion in atrial fibrillation patients with previous intracranial bleeding: A national multicenter study.

[1]  Jeroen J. Bax,et al.  2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association of Cardio-Thoracic Surgery (EACTS). , 2020, European heart journal.

[2]  A. Camm,et al.  EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion - an update. , 2019, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[3]  Hugh Calkins,et al.  2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation. , 2019, Circulation.

[4]  M. García-Fernández,et al.  Prevalence of extra-appendage thrombosis in non-valvular atrial fibrillation and atrial flutter in patients undergoing cardioversion: a large transoesophageal echo study. , 2019, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[5]  S. Kische,et al.  Evaluating Real-World Clinical Outcomes in Atrial Fibrillation Patients Receiving the WATCHMAN Left Atrial Appendage Closure Technology: Final 2-Year Outcome Data of the EWOLUTION Trial Focusing on History of Stroke and Hemorrhage , 2019, Circulation. Arrhythmia and electrophysiology.

[6]  P. Berne,et al.  Left Atrial Appendage Occlusion in High Bleeding Risk Patients , 2019, Journal of interventional cardiology.

[7]  H. Huttner,et al.  Management of oral anticoagulation after intracerebral hemorrhage , 2019, International journal of stroke : official journal of the International Stroke Society.

[8]  P. Berne,et al.  Nonvalvular atrial fibrillation in high-hemorrhagic-risk patients: state of the art of percutaneous left atrial appendage occlusion , 2019, Journal of cardiovascular medicine.

[9]  V. Reddy,et al.  Device-Related Thrombus After Left Atrial Appendage Closure: Incidence, Predictors, and Outcomes , 2018, Circulation.

[10]  G. Lip,et al.  Major bleeding and intracranial hemorrhage risk prediction in patients with atrial fibrillation: Attention to modifiable bleeding risk factors or use of a bleeding risk stratification score? A nationwide cohort study. , 2018, International journal of cardiology.

[11]  S. Kische,et al.  Efficacy and safety of left atrial appendage closure with WATCHMAN in patients with or without contraindication to oral anticoagulation: 1-Year follow-up outcome data of the EWOLUTION trial. , 2017, Heart rhythm.

[12]  M. Rosenqvist,et al.  Left atrial appendage occlusion versus standard medical care in patients with atrial fibrillation and intracerebral haemorrhage: a propensity score-matched follow-up study. , 2017, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[13]  B. Meier,et al.  Patients with intracranial bleeding and atrial fibrillation treated with left atrial appendage occlusion: Results from the Amplatzer Cardiac Plug registry. , 2017, International journal of cardiology.

[14]  S. Olindo,et al.  Left Atrial Appendage Closure in Patients with Atrial Fibrillation and Previous Intracerebral Hemorrhage. , 2017, Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association.

[15]  Dhanunjaya R. Lakkireddy,et al.  Percutaneous left atrial appendage occlusion: the Munich consensus document on definitions, endpoints, and data collection requirements for clinical studies , 2016, Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology.

[16]  P. Kirchhof,et al.  2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. , 2016, European heart journal.

[17]  J. Saw,et al.  Left Atrial Appendage Closure for Atrial Fibrillation Is Safe and Effective After Intracranial or Intraocular Hemorrhage. , 2016, The Canadian journal of cardiology.

[18]  B. Meier,et al.  Left atrial appendage occlusion for stroke prevention in atrial fibrillation: multicentre experience with the AMPLATZER Cardiac Plug. , 2016, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

[19]  G. Lip,et al.  Recalibration of the HAS-BLED Score: Should Hemorrhagic Stroke Account for One or Two Points? , 2016, Chest.

[20]  S. Greenberg,et al.  Association Between Blood Pressure Control and Risk of Recurrent Intracerebral Hemorrhage. , 2015, JAMA.

[21]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2015, Stroke.

[22]  Saibal Kar,et al.  Percutaneous left atrial appendage closure vs warfarin for atrial fibrillation: a randomized clinical trial. , 2014, JAMA.

[23]  D. Krieger,et al.  European Stroke Organisation (ESO) Guidelines for the Management of Spontaneous Intracerebral Hemorrhage , 2014, International journal of stroke : official journal of the International Stroke Society.

[24]  D. Singer,et al.  Physician practices regarding contraindications to oral anticoagulation in atrial fibrillation: findings from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry. , 2014, American heart journal.

[25]  R. Veltkamp,et al.  Left atrial appendage occlusion in atrial fibrillation after intracranial hemorrhage , 2014, Neurology.

[26]  E. Antman,et al.  Edoxaban versus warfarin in patients with atrial fibrillation. , 2013, The New England journal of medicine.

[27]  Michael Tin Chung Poon,et al.  Long-term prognosis after intracerebral haemorrhage: systematic review and meta-analysis , 2013, Journal of Neurology, Neurosurgery & Psychiatry.

[28]  C. Cannon,et al.  Triple Oral Antithrombotic Therapy in Atrial Fibrillation and Coronary Artery Stenting , 2013, Clinical cardiology.

[29]  M. Wallander,et al.  Mortality after hemorrhagic stroke , 2013, Neurology.

[30]  Petr Neuzil,et al.  Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology). , 2013, Journal of the American College of Cardiology.

[31]  D. Atar,et al.  Apixaban versus warfarin in patients with atrial fibrillation. , 2011, The New England journal of medicine.

[32]  G. Breithardt,et al.  Rivaroxaban versus warfarin in nonvalvular atrial fibrillation. , 2011, The New England journal of medicine.

[33]  Gregory Y H Lip,et al.  A novel user-friendly score (HAS-BLED) to assess 1-year risk of major bleeding in patients with atrial fibrillation: the Euro Heart Survey. , 2010, Chest.

[34]  C. Anderson,et al.  Guidelines for the Management of Spontaneous Intracerebral Hemorrhage: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association , 2010, Stroke.

[35]  Gregory Y H Lip,et al.  Refining clinical risk stratification for predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-based approach: the euro heart survey on atrial fibrillation. , 2010, Chest.

[36]  S. Yusuf,et al.  Dabigatran versus warfarin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[37]  Salim Yusuf,et al.  Effect of clopidogrel added to aspirin in patients with atrial fibrillation. , 2009, The New England journal of medicine.

[38]  T. Wilkinson,et al.  The risk of recurrent stroke after intracerebral haemorrhage , 2007, Journal of Neurology, Neurosurgery & Psychiatry.

[39]  M. Woodward,et al.  Prior Events Predict Cerebrovascular and Coronary Outcomes in the PROGRESS Trial , 2006, Stroke.

[40]  D. Singer,et al.  Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis , 2003, Stroke.

[41]  J. Odell,et al.  Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. , 1996, The Annals of thoracic surgery.